A needle in the haystack - The dire straits of needle exchange in Hungary Health policies, systems and management in high-income countries

BMC Public Health

Volumn 16, Issue 1, 2016, Pages

  Gyarmathy, V Anna ^a,b   Csák, Róbert ^c,d   Bálint, Katalin ^b   Bene, Eszter ^b   Varga, András Erno ^b   Varga, Mónika ^e   Csiszér, Nóra ^e   Vingender, István ^b   Rácz, József ^b,c,d  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c Blue Point Outpatient and Prevention Centre   (Hungary)

^d EÖTVÖS LORÁND UNIVERSITY   (Hungary)

^e Drug Prevention Foundation   (Hungary)

Author keywords

Drug policy; Harm reduction; Hungary; Needle exchange; People who inject drugs

Indexed keywords

PSYCHOTROPIC AGENT;

COMMUNICABLE DISEASE CONTROL; COMPLICATION; EPIDEMIC; GREECE; HARM REDUCTION; HIV INFECTIONS; HUMAN; HUNGARY; NEEDLE; NEEDLE SHARING; PREVENTIVE HEALTH SERVICE; PROCEDURES; ROMANIA; SUBSTANCE ABUSE; SYRINGE; TRANSMISSION;

COMMUNICABLE DISEASE CONTROL; DISEASE OUTBREAKS; GREECE; HARM REDUCTION; HIV INFECTIONS; HUMANS; HUNGARY; NEEDLE SHARING; NEEDLE-EXCHANGE PROGRAMS; NEEDLES; PSYCHOTROPIC DRUGS; ROMANIA; SUBSTANCE ABUSE, INTRAVENOUS; SYRINGES;

EID: 84958243003     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/s12889-016-2842-2     Document Type: Article

References (37)

1. Gyarmathy VA, Neaigus A, Miller M, Friedman SR, Des Jarlais DC. Risk correlates of prevalent HIV, hepatitis B virus, and hepatitis C virus infections among noninjecting heroin users. J Acquir Immune Defic Syndr. 2002;30:448-56.
2. Des Jarlais DC, Marmor M, Paone D, Titus S, Shi Q, Perlis TE, et al. HIV incidence among injecting drug users in New York City syringe-exchange programmes. The Lancet. 1996;348:987-91.
3. MacArthur GJ, van Velzen E, Palmateer N, Kimber J, Pharris A, Hope V, et al. Interventions to prevent HIV and Hepatitis C in people who inject drugs: A review of reviews to assess evidence of effectiveness. Int J Drug Policy. 2014;25:34-52.
4. Vickerman P, Hickman M, Rhodes T, Watts C. Model projections on the required coverage of syringe distribution to prevent HIV epidemics among injecting drug users. J Acquir Immune Defic Syndr. 2006;42:355-61.
5. Aspinall EJ, Nambiar D, Goldberg DJ, Hickman M, Weir A, Van Velzen E, et al. Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis. Int J Epidemiol. 2014;43:235-48.
6. Hagan H, Pouget ER, Des J. A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs. J Infect Dis. 2011;204:74-83.
7. Palmateer N, Kimber J, Hickman M, Hutchinson S, Rhodes T, Goldberg D. Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews. Addiction. 2010;105:844-59.
8. Turner KM, Hutchinson S, Vickerman P, Hope V, Craine N, Palmateer N, et al. The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence. Addiction. 2011;106:1978-88.
9. Van Den Berg C, Smit C, Van Brussel G, Coutinho R, Prins M. Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users. Addiction. 2007;102:1454-62.
10. Hyshka E, Strathdee S, Wood E, Kerr T. Needle exchange and the HIV epidemic in Vancouver: lessons learned from 15 years of research. Int J Drug Policy. 2012;23:261-70.
11. Abdul-Quader AS, Feelemyer J, Modi S, Stein ES, Briceno A, Semaan S, et al. Effectiveness of structural-level needle/syringe programs to reduce HCV and HIV infection among people who inject drugs: a systematic review. AIDS Behav. 2013;17:2878-92.
12. Des Jarlais DC. Systematic review research on needle/syringe programs and opiate substitution programs in low- and middle-income countries. J Food Drug Anal. 2013;21:S59-61.
13. WHO, UNODC, UNAIDS. Technical Guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users, 2012 revision. Geneva: World Health Organization; 2012.
14. Des Jarlais DC, Pinkerton S, Hagan H, Guardino V, Feelemyer J, Cooper H, et al. 30 Years on Selected Issues in the Prevention of HIV among Persons Who Inject Drugs. Adv Prev Med. 2013;2013:346372.
15. UNODC. World Drug Report - Available at www.unodc.org/wdr2015/. 2015. Last accessed: 12 February 2016
16. Iversen J, Wand H, Topp L, Kaldor J, Maher L. Extremely low and sustained HIV incidence among people who inject drugs in a setting of harm reduction. AIDS. 2014;28:275-8.
17. Mathers BM, Degenhardt L, Ali H, Wiessing L, Hickman M, Mattick RP, et al. HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage. Lancet. 2010;375:1014-28.
18. Tempalski B, Cooper HL, Friedman SR, Des J, Brady J, Gostnell K. Correlates of syringe coverage for heroin injection in 35 large metropolitan areas in the US in which heroin is the dominant injected drug. Int J Drug Policy. 2008;19 Suppl 1:S47-58.
19. Gyarmathy VA, Neaigus A, Li N, Ujhelyi E, Caplinskiene I, Caplinskas S, et al. Liquid drugs and high dead space syringes may keep HIV and HCV prevalence high - a comparison of Hungary and Lithuania. Eur Addict Res. 2010;16:220-8.
20. Hungarian National Focal Point. 2011 National Report to the EMCDDA. "Hungary" New developments, trends and in-depth information on selected issues. Budapest: National Focal Point Hungary; 2011.
21. Rácz J, Gyarmathy VA, Csák R. New cases of HIV among a sample of PWIDs in Hungary: false alarm or early warning? Int J Drug Policy 2016;27:13-16.
22. Kral AH, Anderson R, Flynn NM, Bluthenthal RN. Injection risk behaviors among clients of syringe exchange programs with different syringe dispensation policies. J Acquir Immune Defic Syndr. 2004;37:1307-12.
23. Tempalski B, Cooper HL, Friedman SR, Des Jarlais DC, Brady J, Gostnell K. Correlates of syringe coverage for heroin injection in 35 large metropolitan areas in the US in which heroin is the dominant injected drug. Int J Drug Policy. 2008;19 Suppl 1:S47-58.
24. Bluthenthal RN, Malik MR, Grau LE, Singer M, Marshall P, Heimer R. Sterile syringe access conditions and variations in HIV risk among drug injectors in three cities. Addiction. 2004;99:1136-46.
25. Bluthenthal RN, Ridgeway G, Schell T, Anderson R, Flynn NM, Kral AH. Examination of the association between syringe exchange program (SEP) dispensation policy and SEP client-level syringe coverage among injection drug users. Addiction. 2007;102:638-46.
26. Kerr T, Small W, Buchner C, Zhang R, Li K, Montaner J, et al. Syringe sharing and HIV incidence among injection drug users and increased access to sterile syringes. Am J Public Health. 2010;100:1449-53.
27. Hungarian National Focal Point. 2010 National Report to the EMCDDA. Budapest: National Focal Point Hungary; 2010.
28. Tarján A, Dudás M, Gyarmathy VA, Rusvai E, Tresó B, Csohán Á. Emerging risks due to new injecting patterns in Hungary during austerity times. Subst Use Misuse. 2015;50:1-11.
29. Wikipedia. Fidesz. Available at http://en.wikipedia.org/wiki/Fidesz. 2015. Last accessed: 12 February 2016.
30. Gyarmathy VA, Neaigus A, Mitchell MM, Ujhelyi E. The association of syringe type and syringe cleaning with HCV infection among IDUs in Budapest, Hungary. Drug Alcohol Depend. 2009;100:240-7.
31. Novo Nordisk. Why Not Pen Devices? Available at http://press.novonordisk-us.com/bluesheet-issue2/downloads/NovoNordisk-Bluesheet-WhyNotPenDevices.pdf. 2015. Last accessed: 12 February 2016.
32. Zule WA, Bobashev G. High dead-space syringes and the risk of HIV and HCV infection among injecting drug users. Drug Alcohol Depend. 2009;100:204-13.
33. Paintsil E, He H, Peters C, Lindenbach BD, Heimer R. Survival of hepatitis C virus in syringes: implication for transmission among injection drug users. J Infect Dis. 2010;202:984-90.
34. Abdala N, Stephens PC, Griffith BR, Heimer R. Survival of human immunodeficiency virus type 1 in syringes. J Acquir Immune Defic Syndr. 1999;20:73-80.
35. Rácz J, Csák R. [Emergence of novel psychoactive substances among clients of a needle exchange programme in Budapest]. Orv Hetil. 2014;155:1383-94.
36. Hungarian Civil Liberties Union. [Life after the closure of the needle exchange]. Available at https://www.youtube.com/watch?v=IV5RCr-IgvE. Last accessed: 12 February 2016.
37. Gyarmathy VA, Sárosi P. Hepatitis C prevalence among people who inject drugs in Hungary. Lancet Infect Dis. 2015;15:1261-2.